A transition plan developed for the ENGAGE-AF TIMI 48 trial was associated with reduced excess thrombotic and bleeding events in patients moved from one oral anticoagulant to another. In the ...

Analysis of the ROCKET AF trial shows patients are at high risk for stroke when they stop their anticoagulants, underscoring the importance of anticoagulation coverage during the transition to a ...